LADENBURG THALMANN FINANCIAL SERVICES INC. - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 57 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q4 2018$02020.0%0.00%
Q3 2018$0202
+10000.0%
0.00%
Q2 2018$020.0%0.00%
Q1 2018$020.0%0.00%
Q4 2017$020.0%0.00%
Q3 2017$02
-50.0%
0.00%
Q2 2017$040.0%0.00%
Q1 2017$0
-100.0%
4
-99.8%
0.00%
Q4 2016$6,0001,610
+40150.0%
0.00%
Q3 2016$040.0%0.00%
Q2 2016$040.0%0.00%
Q1 2016$040.0%0.00%
Q4 2015$040.00%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q2 2016
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 10,000$13,0000.01%
Stone Ridge Asset Management LLC 30,698$41,0000.00%
WEDBUSH SECURITIES INC 13,500$18,0000.00%
Westside Investment Management, Inc. 2,889$4,040,0000.00%
Wealthspire Advisors, L.P. 11,708$16,0000.00%
Blume Capital Management, Inc. 2,546$3,0000.00%
American Portfolios Advisors 2,729$3,6160.00%
Renaissance Technologies 552,200$732,0000.00%
ROYAL BANK OF CANADA 18$00.00%
UBS Group AG 237$00.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders